Nashville, TN — August 18, 2025 /OrthoSpineNews/ — OrthoSolutions®, a leader in orthopedic innovation, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the SUCCESSION® TTC Nail System, a cutting-edge solution designed to provide tibio-talo-calcaneal (TTC) fusion of the ankle.
The SUCCESSION® TTC Nail System has been engineered to offer surgeons a versatile and reliable option for complex hindfoot procedures. The SUCCESSION® TTC Nail is made of Type II anodized alloy (Ti6A14V) to provide robust stability, alongside intuitive instrumentation to allow streamlined precision, thus enabling an optimized surgical outcome.
“OrthoSolutions® is dedicated to innovation and patient outcomes through evidence-based solutions. The SUCCESSION® TTC nail system reflects our commitment to providing surgeons with improved surgical options,” said US President Kevin Brothen. “We are proud to partner with leading foot and ankle surgeons to offer a system that improves the quality of life for patients.”
Key Features of the SUCCESSION™ TTC Nail System:
- StageLock® Technology – Enables internal compression, independently at both the tibiotalar and subtalar joints.
- Versatile Implant Options – Supports a wide range of patient anatomies and surgical needs.
- Enhanced Procedural Efficiency – Simplified implantation with an intuitive instrumentation system.
- Durable, High-Strength Materials – Provides stability to achieve appropriate bone healing.
For more information about the SUCCESSION® TTC Nail System, please visit www.orthosol.com/us/products/succession-ttc-nail-system/ or contact:
Braxton Howard
Director of Product Marketing
214.789.9901
Braxton.howard@orthosol.com
OrthoSolutions Inc
209 10th Avenue South
Suite #416
Nashville, TN 37203
About OrthoSolutions®
OrthoSolutions® is a specialist orthopedic foot and ankle company that works in partnership with surgeons to design and develop implants and instrumentation for patients worldwide.
As one of the longest established foot and ankle companies globally, OrthoSolutions® brings 20+ years of experience of working with leading surgeons to deliver evidence-based advances that enable consistent patient outcomes.
